FEATURE ARTICLES
Not only is investment increasing in pharma, but innovation is propelling growth in multiple drug segments, and the people supporting this growth and innovation remain happy.
- M&A In GLP-1 Technology: Practical Recommendations And Best Practices
- Makary Talks Faster Drug Reviews, 'Continuous Trials,' DTC Ads
- Process Validation: Working Toward Harmonization Of Terms Used To Identify Validation Lots
- ISPE Awards 8 Innovative Pharma Facilities
- The Transition To E-Labeling Is More Than Uploading PDFs
- Are You Still Evaluating CMOs When You Really Need A CDMO?
- Program Manager Alignment And Integration: Best Practices When Working With A CDMO
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-1441662840-lab-team-communication-collaboration]( "Design Testing Strategies To Develop A Drug-Device Combination Product")
Design Testing Strategies To Develop A Drug-Device Combination ProductLeveraging the expertise and experience of a trusted partner can reduce risk and accelerate the time to market for drug-device combination products by creating an optimal Validation Master Plan.
-
Achieve Higher Targeted Concentrations9/30/2025
Single-pass TFF streamlines downstream processing by reducing footprint, shear exposure, and hold-up volumes. Learn how this approach is advancing efficiency across therapeutic and vaccine production.
-
Accelerated API Manufacturing: Combining All Process Development Stages5/16/2024
During early-stage development, utilize the key considerations outlined in this paper to avoid common pitfalls and expedite the transition from molecule to market.
-
Leveraging 3 Distinct Resins To Provide Effective Impurity Removal For mAbs And Novel Antibody Derivatives11/3/2025
Due to the complexity of bispecifics, Fc-fusion proteins, and Fab fragments, their manufacturing poses added purification challenges and requires a robust toolkit of purification techniques.
-
Single-Use Technology And Environmental Responsibility In Biopharmaceuticals3/27/2025
Learn about strategies such as regional manufacturing and advanced single-use systems and their potential to minimize carbon footprint and enhance sustainable biomanufacturing.
-
Optimizing DSP Development: Faster Timelines, Lower Costs, And High-Quality Processes4/8/2025
The biopharmaceutical industry faces growing downstream processing challenges in purifying complex biologics efficiently and at scale.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Intuitive Bioprocess Scale-Up From Bench Scale To Pilot Scale
- Powder Rheology: Gateway For Tablet Sticking Insights
- Quantitative Determination Of Amorphous And Crystalline Drug In Polymer Microspheres
- UPLC-MS/MS Determination Of GLP-1 Analogue
- Simplify Process Scale-Up With An Innovative Single-Use Bioreactor
NEWSLETTER ARCHIVE
- 11.11.25 -- Better Delivery, Better Outcomes: Simplifying Dosing With Nanoforming
- 11.11.25 -- DNA-To-IND In Record Time? The Blueprint For Accelerating Biologics
- 11.10.25 -- From Storage To Cell Culture: Smarter Bioproduction Starts Here
- 11.10.25 -- Considerations For Realizing A Successful Combination Products Program
- 11.08.25 -- Pharmaceutical Online Best Of October
INDUSTRY NEWS
-
![business peope negotiating-GettyImages-637902194]( "9 Drugs Granted Fast Track By FDA's Voucher Program")
9 Drugs Granted Fast Track By FDA's Voucher ProgramWith targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
![Pharmaceutical sorting machine, pills-GettyImages-1499814881]( "Leaders In The Excipient Market: Region And Type")
Leaders In The Excipient Market: Region And TypeThough North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
![GettyImages-2189405678-GLP-1-obesity]( "Pfizer Strengthens Obesity Foothold With Metsera Acquisition")
Pfizer Strengthens Obesity Foothold With Metsera AcquisitionAfter discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
![weight loss, diabetes, insulin pen-GettyImages-2196049931]( "FDA Cracks Down On GLP-1 Imports")
FDA Cracks Down On GLP-1 ImportsGLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
-
![Dollar Icon from Medical pills-GettyImages-1708867150]( "Oregon Court Upholds Drug Price Transparency Law")
Oregon Court Upholds Drug Price Transparency LawThe law was first enacted in 2018, followed by a lawsuit by Pharmaceutical Research and Manufacturers of America (PhRMA) in 2019, claiming an infringement of free speech for pharmaceutical companies and violation of public property. PhRMA asked the court to bar Oregon from enforcing the law.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
AES Cleanroom Technology Establishes New Office In Research Triangle Park To Support Regional Drug Manufacturing Growth11/11/2025
AES Cleanroom Technology, an award-winning leader in modular cleanroom design and construction, has opened a new regional office in Research Triangle Park (RTP), reinforcing its commitment to serving the Southeast’s fast-growing life sciences, biotechnology, and advanced manufacturing sectors.
-
Federal Equipment Announces Diagnostics Laboratory Equipment Auction11/10/2025
Federal Equipment held in conjunction with Proxio Group announces diagnostics laboratory equipment auction.
-
CDMO Codis Launches As Commercial Spray Drying And Amorphous Solid Dispersions Provider10/31/2025
Codis officially launches as a new global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions (ASD), and particle engineering technologies. Formed through the integration of Particle Dynamics in the US and the Haverhill, UK spray drying facility previously operated by EUROAPI, Codis combines decades of regulatory expertise and manufacturing strength under one brand.
-
Eli Lilly Announces $1.2 Billion Investment To Expand Puerto Rico Manufacturing Site For Next-Gen Oral Medicines10/30/2025
Eli Lilly and Company (NYSE: LLY) announced today a planned investment of more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico. This new investment will integrate advanced technologies and expand production capacity within the existing campus to support the company's growing portfolio of oral solid medicines in cardiometabolic health, neuroscience, oncology and immunology.
